Does TRIAMTERENE Cause Malignant neoplasm progression? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TRIAMTERENE (Triamterene). This represents 1.5% of all adverse event reports for TRIAMTERENE.
5
Reports of Malignant neoplasm progression with TRIAMTERENE
1.5%
of all TRIAMTERENE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TRIAMTERENE?
Of the 5 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIAMTERENE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TRIAMTERENE Cause?
Coma (60)
Gastrooesophageal reflux disease (60)
Pneumonia aspiration (60)
Somnolence (60)
Underdose (39)
Drug hypersensitivity (37)
Off label use (28)
Completed suicide (25)
Drug ineffective (23)
Lymphopenia (22)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TRIAMTERENE Alternatives Have Lower Malignant neoplasm progression Risk?
TRIAMTERENE vs TRIATEC
TRIAMTERENE vs TRIAZOLAM
TRIAMTERENE vs TRICHLORMETHIAZIDE
TRIAMTERENE vs TRICLOSAN
TRIAMTERENE vs TRIENTINE